Certainly due for a re-rating now the repeatability of earnings is de-risked (ie reliance on performance fees replaced by asset based fees deducted irrespective of performance).
Thinking 14-16 dollar range is probably around fair value on a peer to peer basis. They still have significant momentum with net flows and 30b might not be an unrealistic end of year target in my view.
New products perhaps coming to market this year?
- Forums
- Charts
- chart for veecat
MFG
magellan financial group limited
Add to My Watchlist
0.00%
!
$8.49

Certainly due for a re-rating now the repeatability of earnings...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$8.49 |
Change
0.000(0.00%) |
Mkt cap ! $1.461B |
Open | High | Low | Value | Volume |
$8.50 | $8.67 | $8.48 | $3.088M | 361.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1950 | $8.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.59 | 5048 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 10603 | 8.300 |
1 | 1175 | 8.200 |
1 | 1124 | 8.150 |
1 | 1242 | 8.050 |
3 | 4000 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
8.590 | 3098 | 1 |
8.630 | 1000 | 1 |
8.650 | 3409 | 2 |
8.690 | 5000 | 2 |
8.700 | 3026 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MFG (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online